A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients. 1995

N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry, Tokyo, Japan.

Polysomnographic examinations (PSG) were performed on 6 male schizophrenic outpatients who were being treated with benzodiazepine (BZD) hypnotics in combination with neuroleptics and 6 healthy male volunteers. In schizophrenic subjects, zopiclone (ZPC), 15 mg/day, was substituted for the BZD hypnotics, and PSGs were recorded again during ZPC therapy. All-night sleep stage scoring was carried out by visual analysis, and computerized period-amplitude analysis of sleep EEG was also performed. The schizophrenics showed marked reduction in the amount of slow-wave sleep (SWS) and in the number of delta half-waves during all-night sleep, especially those with higher amplitude, as compared to the normals. The number of delta half-waves in the patients was markedly reduced during the first sleep cycle. The average amplitude of delta half-waves during all-night sleep in the schizophrenics was significantly lower than that in the normals. The half-wave count of total delta waves in the schizophrenics was higher during treatment with ZPC than with BZDs, although no significant differences were observed in the amount of SWS between the two treatments. Soundness of sleep in the subjective sleep assessment was better evaluated during treatment with ZPC than BZDs. These results suggest that reduction of SWS in schizophrenia may be attributable mainly to the decrease in the number of delta waves with higher amplitude and that ZPC may induce deeper sleep in schizophrenics than BZDs.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
August 1995, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
September 1992, The Japanese journal of psychiatry and neurology,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
August 1996, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
October 1993, Sleep,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
September 1995, Biological psychiatry,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
July 2004, Pharmacopsychiatry,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
February 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
January 1998, Life sciences,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
December 1981, Psychiatry research,
N Kajimura, and M Kato, and T Okuma, and M Sekimoto, and T Watanabe, and K Takahashi
November 1988, Biological psychiatry,
Copied contents to your clipboard!